At a glance
ClinicalIndex Comparison RecordN/ACompleted· 69 enrolled
Drug / intervention
Implantation of anchored Beacon transponder in the lungdevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Evaluating an Anchored Transponder in Lung Cancer Patients Receiving Radiation Therapy
In Brief
A clinical study evaluating Implantation of anchored Beacon transponder in the lung for Lung Cancer. Completed, enrolled 69 participants across 10 sites in 4 countries.
Detailed Summary
Clinical study investigating the feasibility and safety of using an anchored Calypso transponder in the airways of the lung for real-time monitoring of tumor location during radiotherapy
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsLung Cancer
CountriesGermany, South Africa, Switzerland, United States
Collaborators--
Timeline
N/ACompletedFinished
2011201220132014201520162017201820192020202120222023202420252026
Enrollment StartOct 2010
First PostedJul 2011
Primary CompletionDec 2016
Study CompletionJan 2017
TodayJul 2026
First PostedJul 19, 2011
Enrollment StartOct 1, 2010
Primary CompletionDec 1, 2016
Study CompletionJan 1, 2017
TodayJul 2, 2026
Enrollment to primary: 6.2 yearsPosted 15.0 years ago
Interventions
Implantation of anchored Beacon transponder in the lungdevice
Anchored Beacon transponder has an anchoring feature to secure it in the small airways of the lung.